Anterior chamber migration of ozurdex implants

Simple item page
dc.contributor.authorKayıkcıoğlu Ö.
dc.contributor.authorDoğruya S.
dc.contributor.authorSarıgül C.
dc.contributor.authorMayalı H.
dc.contributor.authorKurt E.
dc.date.accessioned2024-07-22T08:08:02Z
dc.date.available2024-07-22T08:08:02Z
dc.date.issued2020
dc.description.abstractWe present patient characteristics and follow-up results of cases with anterior chamber dexamethasone implant migration. The common feature of all six presented cases was vitrectomized eyes. Four of the patients had sutured intraocular lens (IOL) implantation due to complicated cataract surgery, one had combined retinal detachment surgery with sutured IOL implantation, and one had vitrectomy for diabetic intravitreal hemorrhage cleaning and uncomplicated cataract surgery. Anterior chamber implant migration caused corneal edema in all cases and elevated intraocular pressure in three cases. In two cases, the dexamethasone implant was directed into the vitreous cavity after maximum pupillary dilation and corneal manipulation with cotton tip applicator with the patient in reverse Trendelenburg position. There was no other complication until dexamethasone implant degradation, with clear cornea at final examination. In two cases, the implant was removed from the anterior chamber by aspiration, but keratoplasty surgery was planned due to endothelial cell loss and persistent corneal edema during follow-up. In the last two cases, the dexamethasone implant was redirected into the vitreous chamber with a 23-gauge catheter and anterior chamber maintainer but they migrated into the anterior chamber again. In one of these patients, the implant was aspirated by catheter and corneal transplantation was performed due to corneal edema, while the other patient’s implant was redirected into the vitreous chamber with no further anterior migration. The risk of dexamethasone implants migrating into the anterior chamber of vitrectomized eyes and those with sutured IOL implantation should be kept in mind and the patient should be informed and advised to see an ophthalmologist immediately before permanent corneal endothelial damage occurs. © 2020 by Turkish Ophthalmological Association.
dc.identifier.DOI-ID10.4274/tjo.galenos.2019.43778
dc.identifier.issn21498709
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14227
dc.language.isoEnglish
dc.publisherTurkish Ophthalmology Society
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectAnterior Chamber
dc.subjectDexamethasone
dc.subjectDrug Implants
dc.subjectForeign-Body Migration
dc.subjectHumans
dc.subjectMacular Edema
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectTomography, Optical Coherence
dc.subjectdexamethasone
dc.subjectdexamethasone
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectcase report
dc.subjectcataract
dc.subjectclinical article
dc.subjectcornea edema
dc.subjectdevice migration
dc.subjectfemale
dc.subjectfluorescence angiography
dc.subjectfollow up
dc.subjecthuman
dc.subjectintraocular pressure
dc.subjectkeratopathy
dc.subjectkeratoplasty
dc.subjectmacular edema
dc.subjectmale
dc.subjectmiddle aged
dc.subjectmydriasis
dc.subjectoptical coherence tomography
dc.subjectpars plana vitrectomy
dc.subjectpseudophakia
dc.subjectscar
dc.subjectslit lamp microscopy
dc.subjectvisual acuity
dc.subjectadverse device effect
dc.subjectanterior eye chamber
dc.subjectdrug implant
dc.subjectforeign body
dc.subjectinjury
dc.subjectprocedures
dc.titleAnterior chamber migration of ozurdex implants
dc.typeArticle

Files

Collections

Scopus Koleksiyonu